Cargando…
Correction: Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia
Autores principales: | Sun, Haibo, Lin, De-Chen, Guo, Xiao, Masouleh, Behzad Kharabi, Gery, Sigal, Cao, Qi, Alkan, Serhan, Ikezoe, Takayuki, Akiba, Chie, Paquette, Ronald, Chien, Wenwen, Müller-Tidow, Carsten, Jing, Yang, Agelopoulos, Konstantin, Müschen, Markus, Koeffler, H. Phillip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610033/ https://www.ncbi.nlm.nih.gov/pubmed/28969101 http://dx.doi.org/10.18632/oncotarget.20707 |
Ejemplares similares
-
Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia
por: Sun, Haibo, et al.
Publicado: (2016) -
Valosin-Containing Protein/p97 as a Novel Therapeutic Target in Acute Lymphoblastic Leukemia
por: Gugliotta, Gabriele, et al.
Publicado: (2017) -
Metabolic Regulation of Innate Lymphoid Cell-Mediated Tissue Protection—Linking the Nutritional State to Barrier Immunity
por: Wilhelm, Christoph, et al.
Publicado: (2017) -
Drugging the unfolded protein response in acute leukemias
por: Kharabi Masouleh, Behzad, et al.
Publicado: (2015) -
Deregulated expression of the HSP40 family members Auxilin-1 and -2 is indicative of proteostasis imbalance and predicts patient outcome in Ph(+) leukemia
por: Vieri, Margherita, et al.
Publicado: (2016)